BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7989950)

  • 1. Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors.
    Ravikumar TS; Pizzorno G; Bodden W; Marsh J; Strair R; Pollack J; Hendler R; Hanna J; D'Andrea E
    J Clin Oncol; 1994 Dec; 12(12):2723-36. PubMed ID: 7989950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumors.
    Ku Y; Fukumoto T; Tominaga M; Iwasaki T; Maeda I; Kusunoki N; Obara H; Sako M; Suzuki Y; Kuroda Y; Saitoh Y
    Am J Surg; 1997 Feb; 173(2):103-9. PubMed ID: 9074373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: a phase I study.
    Curley SA; Newman RA; Dougherty TB; Fuhrman GM; Stone DL; Mikolajek JA; Guercio S; Guercio A; Carrasco CH; Kuo MT
    Ann Surg Oncol; 1994 Sep; 1(5):389-99. PubMed ID: 7850540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic intra-arterial interferon alpha 2b-based immunotherapy combined with 5-fluorouracil (5-FU)-based systemic chemotherapy for patients with hepatocellular carcinoma (HCC) not responsive and/or not eligible for conventional treatments: a pilot study.
    Vitale FV; Romeo P; Vasta F; Panebianco V; Calì S; Rotondo S; Ferraù F; La Greca M
    Anticancer Res; 2007; 27(6B):4077-81. PubMed ID: 18225574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of repeated percutaneous isolated liver chemoperfusion in local control of unresectable hepatocellular carcinoma.
    Ku Y; Tominaga M; Iwasaki T; Fukumoto T; Muramatsu S; Kusunoki N; Sugimoto T; Suzuki Y; Kuroda Y; Saitoh Y
    Hepatogastroenterology; 1998; 45(24):1961-5. PubMed ID: 9951848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical-pharmacological evaluation of percutaneous isolated hepatic infusion of doxorubicin in patients with unresectable liver tumors.
    Hwu WJ; Salem RR; Pollak J; Rosenblatt M; D'Andrea E; Leffert JJ; Faraone S; Marsh JC; Pizzorno G
    Oncol Res; 1999; 11(11-12):529-37. PubMed ID: 10905565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pilot study on high-dose intraarterial chemotherapy with direct hemoperfusion under hepatic venous isolation in patients with advanced hepatocellular carcinoma.
    Ku Y; Fukumoto T; Iwasaki T; Tominaga M; Samizo M; Nishida T; Kuroda Y; Hirota S; Sako M; Obara H
    Surgery; 1995 May; 117(5):510-9. PubMed ID: 7740422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil.
    Kerr DJ; Ledermann JA; McArdle CS; Buckels J; Neoptolemos J; Seymour M; Doughty J; Budden J; Taylor I
    J Clin Oncol; 1995 Dec; 13(12):2968-72. PubMed ID: 8523062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of systemic drug exposure after hepatic arterial infusion of doxorubicin with complete hepatic venous isolation and extracorporeal chemofiltration.
    Curley SA; Byrd DR; Newman RA; Ellis HJ; Chase J; Carrasco CH; Cleary K; Bodden W; Hohn DC
    Surgery; 1993 Sep; 114(3):579-85. PubMed ID: 8367814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I/II study of continuous intra-arterial chemotherapy using an implantable reservoir for the treatment of liver metastases from breast cancer: a Japan Clinical Oncology Group (JCOG) study 9113. JCOG Breast Cancer Study Group.
    Ikeda T; Adachi I; Takashima S; Ogita M; Aoyama H; Sano M; Ando J; Tabei T; Tominaga T; Enomoto K; Kanda K; Fukutomi T; Shimoyama M
    Jpn J Clin Oncol; 1999 Jan; 29(1):23-7. PubMed ID: 10073147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemohormonal therapy of unresectable hepatocellular carcinoma.
    Uchino J; Une Y; Sato Y; Gondo H; Nakajima Y; Sato N
    Am J Clin Oncol; 1993 Jun; 16(3):206-9. PubMed ID: 8393272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic artery infusion of doxorubicin with hepatic venous drug extraction.
    August DA; Verma N; Andrews JC; Vaerten MA; Brenner DE
    J Surg Res; 1994 Jun; 56(6):611-9. PubMed ID: 8015319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].
    Naganuma A; Toyoda M; Hamada T; Hagiwara S; Yanagisawa M; Kosone T; Arai H; Abe T; Takagi H
    Gan To Kagaku Ryoho; 2007 May; 34(5):729-34. PubMed ID: 17496446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma.
    Park JY; Ahn SH; Yoon YJ; Kim JK; Lee HW; Lee DY; Chon CY; Moon YM; Han KH
    Cancer; 2007 Jul; 110(1):129-37. PubMed ID: 17508408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraarterial infusion of high-dose adriamycin for unresectable hepatocellular carcinoma using direct hemoperfusion under hepatic venous isolation.
    Ku Y; Saitoh M; Iwasaki T; Tominaga M; Maekawa Y; Shiki H; Samizo M; Fukumoto T; Kuroda Y; Sako M
    Eur J Surg Oncol; 1993 Aug; 19(4):387-92. PubMed ID: 8395412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New approach for unresectable primary liver cancer--intra-arterial combination chemotherapy during and after operation with local injection of ethanol].
    Shiga T; Noguchi T; Nishimaki K; Kudo M
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2765-8. PubMed ID: 2551220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of percutaneous hepatic venous isolation and charcoal hemoperfusion for high-dose chemotherapy for hepatoma].
    Ku Y; Tominaga M; Maeda I; Iwasaki T; Kuroda Y; Saitoh Y
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1486-8. PubMed ID: 7574739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.
    Cantore M; Mambrini A; Fiorentini G; Rabbi C; Zamagni D; Caudana R; Pennucci C; Sanguinetti F; Lombardi M; Nicoli N
    Cancer; 2005 Apr; 103(7):1402-7. PubMed ID: 15726542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous isolated liver perfusion for treatment of hepatic malignancy: preliminary report.
    Beheshti MV; Denny DF; Glickman MG; Bodden W; Marsh JC; Strair R; Ravikumar TS
    J Vasc Interv Radiol; 1992 Aug; 3(3):453-8. PubMed ID: 1515715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
    Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.